---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-21-001914"
form_type: "8-K"
ticker: "TERN"
cik: "0001831363"
company_name: "Terns Pharmaceuticals, Inc."
filed_at: "2021-09-29T23:59:59+00:00"
generated_at: "2026-06-29T00:46:52.785157+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Terns appoints former AstraZeneca CMO Ann Taylor to board

## Summary
- Ann E. Taylor, M.D. appointed as Class I director effective Sept 28, 2021.
- Dr. Taylor brings >35 years of drug development experience, including CMO of AstraZeneca.
- She will receive an initial option grant of 44,000 shares and $40k annual cash retainer.
- Her expertise in NASH and clinical development supports Terns' pipeline.

## SEC filing metadata
- accession: 0000950170-21-001914
- form_type: 8-K
- ticker: TERN
- cik: 0001831363
- company_name: Terns Pharmaceuticals, Inc.
- filed_at: 2021-09-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831363/000095017021001914/0000950170-21-001914-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831363/000095017021001914/tern-20210928.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-21-001914
- JSON: https://secwatch.observer/filing/0000950170-21-001914.json
- Plain text: https://secwatch.observer/filing/0000950170-21-001914.txt

## Key facts
- Executive change
  Ann E. Taylor was appointed as Director at Terns Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Director
  source text: On September 28, 2021, the Board of Directors (the “Board”) of Terns Pharmaceuticals, Inc. (the “Company”) appointed Ann E. Taylor, M.D. to serve as a Class I director until her successor is duly elected and qualified or until her earlier death, resignation or removal.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831363/000095017021001914/0000950170-21-001914-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.